BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine.
BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine.
Right before BioNTech was due to announce its 2025 results, the company’s co‑founders, Ugur Sahin and Özlem Türeci, revealed they would leave the company to focus on developing next‑generation mRNA ...
BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, will leave the company by 2026 to establish a new venture focused on next-generation mRNA drugs. Although BioNTech's stock plummeted following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results